RiverPark Advisors LLC acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 625 shares of the medical device company’s stock, valued at approximately $27,000. Several other institutional investors have also recently modified their holdings […]